Inhibiting the TGF-beta signalling pathway as a means of cancer immunotherapy. - Wikidata - wikimedia - TriplyDB

Inhibiting the TGF-beta signalling pathway as a means of cancer immunotherapy.

Inhibiting the TGF-beta signalling pathway as a means of cancer immunotherapy.

http://www.wikidata.org/entity/Q35093612

about

Prognostic significance of BMP and activin membrane-bound inhibitor in colorectal cancer The cancer stem cell: evidence for its origin as an injured autoreactive T cell Immune Evasion Strategies of Glioblastoma TGF-β cascade regulation by PPP1 and its interactors -impact on prostate cancer development and therapy Combinatorial selection of a single stranded DNA thioaptamer targeting TGF-beta1 protein Role of transforming growth factor-beta in hematologic malignancies Type III TGF-β receptor downregulation generates an immunotolerant tumor microenvironment.Challenges in immunotherapy presented by the glioblastoma multiforme microenvironment.Endocytosis of the type III transforming growth factor-beta (TGF-beta) receptor through the clathrin-independent/lipid raft pathway regulates TGF-beta signaling and receptor down-regulation.Fractional laser exposure induces neutrophil infiltration (N1 phenotype) into the tumor and stimulates systemic anti-tumor immune response.

P2860

Q24337061-26F7F5E7-74B2-40F0-87C5-AE196A5BA528 Q25256839-015001A1-EA11-4C93-AC38-E908850CB84C Q26765855-222AAB31-904A-4014-BD5E-5D6D6737CB48 Q26862838-F5810147-833E-4BC0-B873-9CFAA44565AC Q33320906-3851BB8E-F5E0-4386-AAF9-FEB482003991 Q36399296-0A7FFB30-1FCF-47E8-A4EF-913531CA4557 Q37123849-4E9E9852-D4CF-415E-9988-B2A96CF0412E Q37970682-C2BC92FB-F581-45B1-92E7-5A2884F818BB Q41177526-F984CD74-FE33-4CB6-895B-6639918832D6 Q41702460-ED3F7856-0B53-4543-B170-0890EA46A669

P2860

Inhibiting the TGF-beta signalling pathway as a means of cancer immunotherapy.

http://www.wikidata.org/entity/Q35093612

description

2003 nî lūn-bûn

@nan

2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Inhibiting the TGF-beta signalling pathway as a means of cancer immunotherapy.

@ast

Inhibiting the TGF-beta signalling pathway as a means of cancer immunotherapy.

@en

type

label

Inhibiting the TGF-beta signalling pathway as a means of cancer immunotherapy.

@ast

Inhibiting the TGF-beta signalling pathway as a means of cancer immunotherapy.

@en

prefLabel

Inhibiting the TGF-beta signalling pathway as a means of cancer immunotherapy.

@ast

Inhibiting the TGF-beta signalling pathway as a means of cancer immunotherapy.

@en

P1433

Q35093612-FFF47DB6-31BA-442E-990B-76E193C3185C

P1476

Q35093612-AD90971B-EF4A-46F9-9DAB-1359F32F183A

P2093

Q35093612-5C93DD46-EF20-4B77-B4A5-E99C0E1EEF54

Q35093612-D0B700BF-0395-4466-BBF9-5996E9934646

P2860

Q35093612-1554D66D-659C-4186-98AC-B9B860F23EB4

Q35093612-2B48E970-AA9C-484A-821B-D352CB9A77DA

Q35093612-2B923318-09E8-4821-8C41-640F7FD68DCD

Q35093612-317297B9-DAFF-4F2A-AB3B-9A170EDA2445

Q35093612-34EA5784-47FC-4480-9689-DFBFE442B8B7

Q35093612-3A846267-0734-456B-B4D9-40F31D70F5F8

Q35093612-3D83E6CF-218C-462A-B113-2EFF431FE3FA

Q35093612-3E26A6B7-6154-493C-AB7E-8DAC9E1FFAA2

Q35093612-3F9D7D41-BB78-4D25-9242-2744F7C513CF

Q35093612-40D87DBD-6740-418B-90CA-F51F4C25B443

P304

Q35093612-843E371C-6A79-4072-A9CC-F5660703327A

P31

Q35093612-B411496A-B5AA-44EE-8D89-4677AAA0BBD7

P356

Q35093612-AC281A4D-6492-457E-905A-B576D01A3540

P407

Q35093612-72F28EA4-E2A7-41B9-9632-6A1E6702811A

P433

Q35093612-ABB16AB9-91DB-4339-BA4F-08A3361FC61E

P478

Q35093612-3B4C2204-06F7-4C7B-9F73-3B8D25A4C06B

P577

Q35093612-39261CC2-47B3-4765-AB70-F4EF3CA88376

P698

Q35093612-13F3DA39-81F5-450C-8451-091DE162C848

P921

Q35093612-1802C923-CCE2-4080-A22E-5C9F27D7A821

P356

14712598.3.2.251

P1433

Expert Opinion on Biological Therapy

P1476

Inhibiting the TGF-beta signalling pathway as a means of cancer immunotherapy.

@en

P2093

Gerard C Blobe

http://www.w3.org/2001/XMLSchema#string

Kellye C Kirkbride

http://www.w3.org/2001/XMLSchema#string

P2860

TGF-beta signal transduction

Requirement of type III TGF-beta receptor for endocardial cell transformation in the heart

Betaglycan binds inhibin and can mediate functional antagonism of activin signalling

SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7

Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability

Disruption of the gene encoding the latent transforming growth factor-beta binding protein 4 (LTBP-4) causes abnormal lung development, cardiomyopathy, and colorectal cancer

Role of transforming growth factor beta in human disease

Functional roles for the cytoplasmic domain of the type III transforming growth factor beta receptor in regulating transforming growth factor beta signaling

Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease

Regulation of immune responses by TGF-beta

P304

251-261

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14712598.3.2.251

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2003-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12662140

http://www.w3.org/2001/XMLSchema#string

P921